﻿<?xml version="1.0" encoding="UTF-8"?>
<records>
  <record>
    <language>eng</language>
    <publisher>Science and Education Publishing</publisher>
    <journalTitle>American Journal of Medical Case Reports</journalTitle>
    <publicationDate>2014-11-11</publicationDate>
    <volume>2</volume>
    <issue>11</issue>
    <startPage>253</startPage>
    <endPage>255</endPage>
    <doi>10.12691/ajmcr-2-11-8</doi>
    <publisherRecordId>AJMCR20142118</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Clinical Application of the Levothyroxine Absorption Test in the Diagnosis of Pseudo-Malabsorption</title>
    <authors>
      <author>
        <name>Muhammad Imran Butt</name>
        <affiliationId>1</affiliationId>
      </author>
      <author>
        <name>Nidhi Gupta</name>
        <affiliationId>1</affiliationId>
      </author>
      <author>
        <name>Hiang Leng Tan</name>
        <email>hiangleng@doctors.org.uk</email>
        <affiliationId>2</affiliationId>
      </author>
      <author>
        <name>Najeeb Waheed</name>
        <affiliationId>3</affiliationId>
      </author>
    </authors>
    <affiliationsList>
      <affiliationName affiliationId="1">Department of Diabetes and Endocrinology, Peterborough City Hospital, Peterborough, UK</affiliationName>
      <affiliationName affiliationId="2">Department of Diabetes and Endocrinology, Weston General Hospital, Weston-super-Mare, UK</affiliationName>
      <affiliationName affiliationId="3">Department of Diabetes and Endocrinology, Hereford County Hospital, Hereford, UK</affiliationName>
    </affiliationsList>
    <abstract language="eng">We present a variation and clinical application of the Levothyroxine Absorption Test (LAT) in the identification of pseudo-malabsorption of levothyroxine in uncontrolled hypothyroidism, for which there is no current gold standard protocol, and a variety of methods proposed in the literature. The LAT was conducted over 5-days with thyroid function tests conducted pre-LAT, then at day 1 and 5. The thyroid stimulating hormone levels became completely suppressed indicating that there had been previous non-compliance with medication.</abstract>
    <fullTextUrl format="pdf">http://pubs.sciepub.com/ajmcr/2/11/8/ajmcr-2-11-8.pdf</fullTextUrl>
    <keywords language="eng">
      <keyword>levothyroxine absorption test</keyword>
      <keyword>non-compliance</keyword>
      <keyword>pseudo-malabsorption</keyword>
    </keywords>
  </record>
</records>